Amber Freed: Fighting Like a Mother to Cure SLC6A1
Amber Freed is the mother of adorable twins, Riley and Maxwell. Maxwell was 18 months old when the Freed family received his devastating diagnosis of SLC6A1. Ms. Freed left her career in equity analysis the day Maxwell was diagnosed and dedicated her life to finding a cure. In 18 months, Amber has single-handedly driven multiple translational treatments forward and become a leader within the rare disease community. Ms. Freed serves as the Founder and CEO of SLC6A1 Connect. SLC6A1 Connect’s work has elevated awareness and created an ecosystem that can systematically help fund and consolidate research and treatment efforts. Her efforts have been highlighted in the Huffington Post, Buzzfeed, Bloomberg, CNBC and many more. Ms. Freed was featured in the best-selling book, Shortcut to Prosperity, as an example of grit well before her skills were put to the ultimate test. Prior to Founding SLC6A1 Connect, Ms. Freed served in a variety of equity and financial analysis roles, most recently in consumer equity research with Janus Henderson Investors. Prior to Janus, Ms. Freed was a Vice President with Stout, Risius & Ross in Houston, Texas, focusing on private company and personal valuations. Ms. Freed has also served in roles with RK Capital Management, Dividend Capital Trust, and KPMG LLP. Ms. Freed attended the University of Denver for both undergraduate and graduate school, receiving degrees in Accounting on an academic scholarship. She was nominated for the Global Genes Rare Champion of Hope Award, is a member of the Rare Advocacy Movement and sits on the Board of CombinedBrain. Amber can be reached at any hour of the day to advance science.